Matina Stevis-Gridneff's April 2021 New York Times investigation reported that von der Leyen had conducted personal text-message negotiations with Pfizer CEO Albert Bourla over the terms of the expanded vaccine contract. The investigation cited multiple sources familiar with the negotiations.

When FOI requests were filed for the texts, the Commission took the position that short personal text messages do not constitute official "documents" under EU transparency regulations and therefore need not be disclosed or retained. The EU Ombudsman found this position did not meet required transparency standards.

Emily O'Reilly's Office of the European Ombudsman issued a formal finding of maladministration against the European Commission in January 2022, stating the Commission had not made adequate efforts to retrieve the messages and that its transparency position was not tenable.

The European Public Prosecutor's Office, the EU's independent anti-corruption prosecutorial body, announced a criminal investigation in January 2023 into the vaccine contract negotiations. The EPPO has jurisdiction over offences affecting EU financial interests.

The European Court of Justice ruled in May 2025 that the Commission's blanket refusal to treat informal messages as subject to transparency obligations was not legally sustainable, and partially ordered disclosure of relevant communications. This represents a significant judicial rebuke of the Commission's position.

Von der Leyen was re-confirmed as European Commission President by the European Parliament in June 2024, following EU elections. Her re-confirmation despite the ongoing Pfizergate controversy is cited by critics as evidence of institutional protection; supporters note she retained majority parliamentary support.

The Commission had established a joint negotiating team for vaccine procurement. Von der Leyen's direct personal negotiations with Bourla bypassed this team's involvement in the expanded contract, raising procedural questions about Commission executive accountability.

Critics have raised the question of whether von der Leyen received personal benefit from the Pfizer relationship. No documentary evidence of personal financial benefit has been produced. The maladministration finding relates to transparency failures, not personal corruption.

The European Court of Justice's May 2025 ruling ordering partial release of European Commission documents related to von der Leyen's Pfizer negotiations represents the EU's own institutional accountability mechanisms functioning — a court overruling the Commission's document-withholding position. This outcome is inconsistent with a fully captured or conspiratorial cover-up: independent EU judicial oversight produced a transparency outcome adverse to the Commission. The process is ongoing, and further document release may clarify or complicate the narrative, but the judicial check is operating as designed.

The European Commission's position on the SMS exchanges rested on EU Regulation 1049/2001 on public access to documents and the argument that informal communications on a personal device did not constitute 'documents' held by the institution. While the ECJ rejected this position, the legal argument was not frivolous — similar questions about whether text messages constitute official records have been litigated in multiple EU member state jurisdictions. The Commission's legal position, however ultimately unsuccessful, was within the bounds of a plausible institutional-law dispute rather than pure obstruction of clearly applicable disclosure requirements.

Matina Stevis-Gridneff's April 2021 New York Times investigation reported that von der Leyen had conducted personal text-message negotiations with Pfizer CEO Albert Bourla over the terms of the expanded vaccine contract. The investigation cited multiple sources familiar with the negotiations.

When FOI requests were filed for the texts, the Commission took the position that short personal text messages do not constitute official "documents" under EU transparency regulations and therefore need not be disclosed or retained. The EU Ombudsman found this position did not meet required transparency standards.

Emily O'Reilly's Office of the European Ombudsman issued a formal finding of maladministration against the European Commission in January 2022, stating the Commission had not made adequate efforts to retrieve the messages and that its transparency position was not tenable.

The European Public Prosecutor's Office, the EU's independent anti-corruption prosecutorial body, announced a criminal investigation in January 2023 into the vaccine contract negotiations. The EPPO has jurisdiction over offences affecting EU financial interests.

The European Court of Justice ruled in May 2025 that the Commission's blanket refusal to treat informal messages as subject to transparency obligations was not legally sustainable, and partially ordered disclosure of relevant communications. This represents a significant judicial rebuke of the Commission's position.

The Commission had established a joint negotiating team for vaccine procurement. Von der Leyen's direct personal negotiations with Bourla bypassed this team's involvement in the expanded contract, raising procedural questions about Commission executive accountability.

Critics have raised the question of whether von der Leyen received personal benefit from the Pfizer relationship. No documentary evidence of personal financial benefit has been produced. The maladministration finding relates to transparency failures, not personal corruption.

Von der Leyen was re-confirmed as European Commission President by the European Parliament in June 2024, following EU elections. Her re-confirmation despite the ongoing Pfizergate controversy is cited by critics as evidence of institutional protection; supporters note she retained majority parliamentary support.

The European Court of Justice's May 2025 ruling ordering partial release of European Commission documents related to von der Leyen's Pfizer negotiations represents the EU's own institutional accountability mechanisms functioning — a court overruling the Commission's document-withholding position. This outcome is inconsistent with a fully captured or conspiratorial cover-up: independent EU judicial oversight produced a transparency outcome adverse to the Commission. The process is ongoing, and further document release may clarify or complicate the narrative, but the judicial check is operating as designed.

The European Commission's position on the SMS exchanges rested on EU Regulation 1049/2001 on public access to documents and the argument that informal communications on a personal device did not constitute 'documents' held by the institution. While the ECJ rejected this position, the legal argument was not frivolous — similar questions about whether text messages constitute official records have been litigated in multiple EU member state jurisdictions. The Commission's legal position, however ultimately unsuccessful, was within the bounds of a plausible institutional-law dispute rather than pure obstruction of clearly applicable disclosure requirements.